Multi-drug resistance (MDR), the most common difficulty in the face of successful cancer chemotherapy, means a cellular resistance to structurally and functionally unrelated chemotherapeutic drugs. 1) One of the mechanisms of MDR is associated with the overexpression of P-glycoprotein (P-gp) in tumor cells, which occurs when cancer cells are exposed to a single hydrophobic cytotoxic agent.
Multi-drug resistance (MDR), the most common difficulty in the face of successful cancer chemotherapy, means a cellular resistance to structurally and functionally unrelated chemotherapeutic drugs. 1) One of the mechanisms of MDR is associated with the overexpression of P-glycoprotein (P-gp) in tumor cells, which occurs when cancer cells are exposed to a single hydrophobic cytotoxic agent. 2, 3) Several generations of P-gp inhibitors, such as verapamil, quinidine, PSC-833, etc., have been reported to reverse MDR in vitro and in vivo, but still failed to be developed for further clinical trials due to their unacceptable adverse effects and toxicities. 4) Therefore, searching for novel MDR reversing agents with strong potency and minimal side effects is necessary. In our previous investigation, we reported that sinenxan A and some derivatives by an enzymatic/chemical approach displayed good activities in MDR cells in vitro and in vivo. [5] [6] [7] [8] In the enzymatical structural modification, Ginkgo cell suspension cultures were found to possess highly regio-and stereo-selective hydroxylation at the 9a position. [7] [8] [9] [10] The substrate specificity of 9a hydroxylase of this type of taxane in Ginkgo cells has been investigated, and some "structure-activity relationships, SAR" between the enzyme and substrate structures has been concluded. [7] [8] [9] [10] [11] As a part of our ongoing work, in order to further investigate and better clarify the substrate specificity of the enzyme, 2a,5a,10b-triacetoxy-14-oxo-taxa-4(20),11-diene (1), a new type of taxadiene with a carbonyl group at C-14 from sinenxan A by a chemical method has been prepared and used as a substrate. 12) In addition, another aim is to obtain more structurally diversified derivatives in the search for more valuable bioactive derivatives that act as MDR reversing agents by biotransformation. Herein, we briefly report the biotransformation of 1 by Gingko cells, the structural elucidation of new compounds, and the MDR reversal activities of metabolites towards MX-1/T and MCF-7/doxorubicin (DOX) cell lines.
Results and Discussion
After incubation with cell cultures of Ginkgo for 6 d, four metabolites 2-5 ( Fig. 1) were obtained by the combination of open silica gel column chromatography and semi-preparative HPLC. On the basis of the IR, NMR and high resolution (HR)-MS spectral data, their structures were established to be 2a,5a-diacetoxy-4b,20-epoxy-10b-hydroxy-14-oxo-taxa-11(12)-ene (2), 2a ,5a ,10b -triacetoxy-14-oxo-taxa-4(20), 12(13)-diene (3), 2a,5a-diacetoxy-10b,11-epoxy-14-oxo-taxa-4(20),12(13)-diene (4), and 2a ,5a -diacetoxy-10b ,11-epoxy-18-hydroxy-14-oxo-taxa-4(20),12(13)-diene (5). Among these, metabolites 2, 3 and 5 were three new compounds. 4 had been previously obtained by chemical methods, and was the first example of a l0,11-epoxy taxoid, its physical and chemical data were in good accordance with those of the previous report. 12) In this bioprocess, we observed several reactions including hydrolysis, epoxidation, rearrangement and hydroxylation, etc. Based upon the comparison of structures of the substrate and metabolites, a plausible bioconversion pathway of 1 to the four products was proposed (Fig. 1) . However, the 9a hydroxylation of 1 was not observed as expected in this case, indicating the high substrate specificity of 9a hydroxylase in Ginkgo cells, although there existed subtle substituent differences at C-14, with a carbonyl group instead of an acetoxyl or a hydroxyl group. [8] [9] [10] The positive HR-electrospray ionization (ESI)-MS spectrum of 2 showed a quasi-molecular ion peak at m/z 457. 2199 13) Thus, the structure of 2 was identified as 2a,5a-diacetoxy-4b,20-epoxy-10b-hydroxy-14-oxo-taxa-11(12)-ene, and its 1 H-NMR spectroscopic data assignments are listed in Table 1 .
Compound 3 was obtained as a white amorphous powder, with an elemental composition of C 26 H 36 O 7 , which was determined by the combined data analysis of HR-ESI-MS and 1 H-and 13 C-NMR spectra. The molecular weight and molecular formula were the same as 1, and the (12) double-bond to C-12 (13) . Thus, the structure of 3 was determined to be 2a,5a,10b-triacetoxy-14-oxo-taxa-4(20),12(13)-diene (3), and the assignments of its 1 H-NMR spectroscopic data are shown in Table 1 .
Compound 4 was a known compound. The stereochemistry of the epoxide ring of 4 was previously estimated by coupling constants between H-10 and both H-9a and H9b. 12) In this study, nuclear Overhauser effect (NOE) difference spectrum experiments have been performed. The integration values of H-9a and H-18 were enhanced when H-10 was irradiated, while the enhancement of integration values of H-9b and H-19 were observed when H-2 was irradiated (Fig. 2) , indicating the a-orientation of H-10. These results further confirmed the stereochemistry of the epoxide rings of compounds 4 (Fig. 2 ). Naturally occurring taxanes have H-2 and H-19 in the b-orientation, while H-10 is a-orientated. Thus, the stereochemistry of H-10 in this enzymatic product was in accordance with those natural compounds. Therefore, the structure of 4 was assigned as 2a,5a-diacetoxy-10b,11-epoxy-14-oxo-taxa-4(20),12 (13) C-NMR spectrum compared with that of 4 at d C 20.6. Furthermore, the positive HR-ESI-MS spectrum of 5 showed a quasi molecular ion peak at m/z 455.2055, consistent with the molecular formula C 24 H 32 O 7 Na, being 16 amu more than 4, suggesting the introduction of a hydroxyl group. This was also confirmed by the IR absorption of the hydroxyl group at 3460 cm
Ϫ1
. Thus, the structure of 5 was elucidated as 2a ,5a -diacetoxy-14-oxo-10b ,11-epoxy-18-hydroxy-taxa-4(20),12(13)-diene, and its 1 H-NMR spectroscopic data are outlined in Table 1 .
1 together with the metabolites 2-5 as reversing agents, combined with taxol at 10 mM, were preliminarily evaluated for MDR reversal activity against the drug-resistant MX-1/T and MCF-7/DOX cell lines. The bioassay results of the tested compounds against MX-1/T and MCF-7/DOX cells are sum- marized in Table 2 . Among all the tested compounds, 1-3 and 5 exhibited substantially weak reversing activities, while compound 4 displayed potent effects against MX-1/T cells. The IC 50 value of taxol co-administered with the reversal agent 4 at 10 mM decreased to 2.22 mM from Ͼ500 mM.
In this paper, cell suspension cultures of G. biloba were employed to convert a taxadiene derived from the natural product sinenxan A to four structurally diversified metabolites (2-5) via different reactions, such as hydrolysis, epoxidation, rearrangement and hydroxylation, etc. The characteristic C-9a hydroxylation of sinenxans by Ginkgo cells did not occur as expected, indicating the narrow substrate specificity of 9a hydroxylase, even toward compounds with subtle structural differences. Furthermore, among these compounds, 4 exhibited greatly significant MDR reversal activity to MX-1/Taxol cells, far more potent than 1 and the other metabolites, suggesting 4 might be a good lead as an MDR reversal agent. In summary, these results showed that biotransformation is a powerful approach to compound structural diversification, and valuable in the process of drug R & D.
Experimental
General Experimental Procedures Optical rotations in CHCl 3 were carried out using a Perkin-Elmer Model-343 digital polarimeter. IR spectra were obtained using a Thermo-Nicolet 5700 spectrophotometer. The 1 H-, 13 C-NMR and NOE difference spectra were recorded in CDCl 3 on Mercury-300 and Varian-400 spectrometers using visual resonances ( 1 H d 7.27, 13 C d 77.0) as an internal reference. Chemical shifts (d) were given in ppm, coupling constants (J) were given in hertz (Hz). HR-ESI-MS were obtained on a Q-trap ESI mass spectrometer. Normal-phase semi-preparative HPLC was performed on a Shiseido HPLC instrument equipped with a YRU-883A RI/UV-bidetector and a YMC Prep-Si stainless steel column (5 mm, 250 mmϫ10 mm i.d., YMC Co., Ltd., Tokyo, Japan) by eluting with the mixtures of n-hexane and ethyl acetate (flow rate 4 ml/min). Silica gel (300-400 mesh, Qingdao Marine Chemical Industry, Qingdao, P. R. China) was employed for column chromatography, and analytical TLC was carried out on pre-coated Si gel GF-254 plates (Qingdao Marine Chemical Industry). The visualization of TLC plates was performed by illuminating at UV 254 nm, and by spraying with 5% H 2 SO 4 in EtOH followed by heating at 105°C.
Substrates and Organism, Media and Cultivation Conditions 2a,5a,10b-Triacetoxy-14-oxo-taxa-4(20),11-diene (1), was prepared as described in the literature.
12) The cell suspension cultures of Ginkgo biloba were cultivated in a 1000 ml Erlenmeyer flask with 330 ml liquid MS media, which was supplemented with 0.5 mg/l of naphthalene acetic acid (NAA), 0.5 mg/l of 6-benzylaminopurine (6-BA) and 0.2 mg/l of 2,4-dichlorophenoxy acetic acid (2, 4-D) . The medium pH was adjusted to 5.8 before autoclaving at 121°C for 25 min. The cultivation procedure was carried out with an inoculum size of 5 g/l of cell cultures which were shaken at 110 rpm at (25Ϯ2)°C in the dark as described previously. 14) Biotransformation and Separation The substrate (1, 500 mg) was dissolved in 10 ml EtOH before use, then uniformly distributed at a final concentration of 50 mg/l among 30 flasks of 15-d-old cell cultures. After an additional 6 d of incubation, the cultures were filtered under reduced pressure, and the filtrate was extracted with ethyl acetate four times. All the extracts were pooled, dried with anhydrous Na 2 SO 4 , and concentrated under a vacuum at 40°C to give 950 mg of residue. The dried cell cultures (120 g) were extracted three times in an ultrasonic bath by an equivalent volume of acetone, and the resulting extracts were pooled and concentrated under a vacuum at 40°C to afford 300 mg of residue. The above two extracts were combined and separated by a combination of open silica gel chromatography and semi-preparative HPLC [mobile phase: n-hexane/ethyl acetate (80/20, v/v)] to afford 1 (110 mg, ca. 22%; analyzed by TLC and 1 H-NMR), 2 (20.6 mg, ca. 5%; t R 16 min), 3 (9.0 mg, t R 8.5 min), 4 (181.3 mg, ca. 36%; t R 12 min), and 5 (6.7 mg, t R 19 min).
2a,5a-Diacetoxy-4b,20-epoxy-10b-hydroxy-14-oxo-taxa-11(12)-ene (2): Colorless amorphous powder. H-NMR spectral data see Table 1 . 1 H-NMR spectral data see Table 1 . Medical College. The drug-resistant sublines of MCF-7/DOX and MX-1/T were established by culturing the cells with gradually increasing concentrations of DOX or taxol, and identified with molecular techniques.
15) The MDR tumor cells were incubated in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS), 100 U/ml of penicillin and 100 mg/ml of streptomycin at 37°C in a humidified atmosphere of 5% CO 2 in air. Cells were subcultured twice every week by digestion with mixture of 0.25% trypsin and 0.01% ethylenediaminetetraacetic acid (EDTA) solution. The procedures were performed as described in the literature. 16) Reversing agents (10 mM) combined with taxol (1, 0.1 mM, 10, 1 nm) were dissolved in 100 ml dimethyl sulfoxide (DMSO) with a final DMSO concentration of 0.1% in each well. Each concentration was tested in three parallel wells, and was treated in MCF-7/DOX and MX-1/T cells to detect the reversal activities of these agents in those resistance cells. The IC 50 values were defined as the taxol concentration that resulted in a 50% reduction in the number of cells compared with control cells after 4 d of incubation, and were determined directly from the semi-logarithmic dose-response curves.
